Earnings Feed
Start Free
Vir Biotechnology, Inc.·4

Jun 10, 6:21 PM ET

Coughlin Timothy 4

4 · Vir Biotechnology, Inc. · Filed Jun 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Vir (VIR) Director Timothy Coughlin Receives 48,000-Share Award

What Happened
Timothy Coughlin, a director of Vir Biotechnology, received equity awards on June 9, 2026 totaling 48,000 shares at a $0.00 acquisition price. The filing shows two non-derivative awards of 8,000 shares each (16,000 RSUs total) and two derivative awards of 16,000 shares each (32,000 stock-option type awards), all reported as grants/awards rather than purchases or sales. No cash was exchanged; these are compensatory awards, not open-market purchases or sales.

Key Details

  • Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (timely filing).
  • Price: $0.00 per share (awarded).
  • Total awarded: 48,000 shares (16,000 RSUs; 32,000 derivative awards/stock options as reported).
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Notable footnotes:
    • RSUs granted pursuant to the issuer’s Equity Incentive Plan (vesting: 1/3 on June 9, 2027, remainder in two equal annual installments; in some RSU awards vest in full on earlier of June 9, 2027 or next annual meeting).
    • Stock-option-type awards vesting: 1/3 on June 9, 2027 with remaining shares vesting in 24 equal monthly installments; in some awards vest in full on earlier of June 9, 2027 or next annual meeting.
  • Filing status: Appears timely (filed next day).

Context

  • RSUs are restricted stock units that convert to shares as they vest; stock-option-type awards are derivative grants that become exercisable according to the vesting schedules above.
  • These awards are compensatory (routine director/employment equity) and do not indicate an immediate buy or sell of stock.
  • No indication in the filing that shares were sold or that a cashless exercise occurred.

Insider Transaction Report

Form 4
Period: 2026-06-09
Vir Biotechnology, Inc.VIR
Coughlin Timothy
Director
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-06-09+8,000→ 8,000 total
  • Award

    Common Stock

    [F1][F3]
    2026-06-09+8,000→ 16,000 total
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-06-09+16,000→ 16,000 total
    Exercise: $8.51Exp: 2036-06-08→ Common Stock (16,000 underlying)
  • Award

    Stock Option (Right to Buy)

    [F5]
    2026-06-09+16,000→ 16,000 total
    Exercise: $8.51Exp: 2036-06-08→ Common Stock (16,000 underlying)
Footnotes (5)
  • [F1]Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  • [F2]1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.
  • [F3]The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
  • [F4]1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.
  • [F5]The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact|2026-06-10

Documents

1 file
  • 4
    wk-form4_1781130089.xmlPrimary

    FORM 4